| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 202.074 | 236.405 | 175.607 | 29.443 | 39.621 |
| Total Income - EUR | - | - | - | - | 0 | 216.995 | 255.788 | 223.421 | 88.166 | 64.866 |
| Total Expenses - EUR | - | - | - | - | 12.409 | 138.143 | 364.151 | 250.247 | 78.886 | 60.463 |
| Gross Profit/Loss - EUR | - | - | - | - | -12.409 | 78.852 | -108.363 | -26.826 | 9.279 | 4.403 |
| Net Profit/Loss - EUR | - | - | - | - | -12.409 | 72.375 | -110.737 | -28.582 | 8.852 | 3.698 |
| Employees | - | - | - | - | 0 | 0 | 1 | 1 | 2 | 1 |
Check the financial reports for the company - Eden Medical Sciences S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 9.770 | 9.585 | 84.897 | 158.288 | 148.635 | 139.403 |
| Current Assets | - | - | - | - | 1.821 | 404.633 | 331.096 | 226.012 | 235.653 | 221.431 |
| Inventories | - | - | - | - | 0 | 245.884 | 67.311 | 51.084 | 14.400 | 14.319 |
| Receivables | - | - | - | - | 1.479 | 129.783 | 131.539 | 155.331 | 196.006 | 189.738 |
| Cash | - | - | - | - | 342 | 28.966 | 132.247 | 19.597 | 25.248 | 17.373 |
| Shareholders Funds | - | - | - | - | -12.198 | 60.408 | -51.669 | -80.411 | -71.316 | -67.219 |
| Social Capital | - | - | - | - | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | - | - | 23.790 | 353.810 | 467.663 | 464.720 | 455.604 | 428.052 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "128 - 128" | |||||||||
| CAEN Financial Year |
128
|
|||||||||
Comments - Eden Medical Sciences S.r.l.